Watching Over Mothers & Babies

02/19/2021

Respiratory Syncytial virus is one of the leading causes of hospitalizations in infants under the age of 12 months. WOMB is actively recruiting for pregnant women who are between 24 and 36 weeks pregnant to participate in a study that will analyze whether antibodies received through vaccination will transfer to their infants. Contact us today to find out more! (520) 881-9662

10/12/2020

Healthy Babies born in RSV season are at risk to contract RSV. One vaccine will be given to healthy pregnant women in the 2nd or 3rd trimester of pregnancy. This will produce sufficient antibody titers to protect against RSV disease via trans-placental transfer to the fetus. This antibody would then help to protect infants early in life, when they are most at risk for severe RSV disease. In the United States, RSV is the leading cause of infant hospitalization, with more than 60,000 hospitalizations of children 12 months of age and younger annually. Maternal immunization to protect infants early in life offers a strategy for preventing this virus in infants. Call us at WOMB (520)881-9662 to see if you Qualify.

Interested in a ${study}? Click this Link and Sign Up for more information. Your local research site will call you with more information.

09/11/2020

We are on ClinicalTrials.gov

A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy. - Full Text View.

09/01/2020

WOMB is enrolling infants for an infant formula clinical research study ByHeart SS-101-18 https://byheart.com/
Infants will be eligible to participate if they are:
Healthy Born at full-term. Birth weight greater than 5 lbs & 8.5 oz.
14 days of age or younger. Tolerant to cow’s milk. Additional criteria may apply. There is no cost to participate. All study-related care and medication are provided at no cost. You may be compensated up-to $550 for your time and travel.

ByHeart is a fully-integrated nutrition brand focused on baby food and formula. We support feeding freedom, and a holistic approach to nutrition & wellness.

09/01/2020

Newborn infants are among the most vulnerable to contracting respiratory syncytial virus (RSV) illnesses, yet there are no vaccines currently available. We are studying an investigational RSV in pregnant women (also known as ‘maternal immunization’), to see if it can protect their infants from RSV illness after they are born. Women in their 2nd or 3rd trimester of may qualify to participate in Maternal Immunization Study for Safety and Efficacy (MATISSE). Visit our study website for more information www.matissersvstudy.com www.womb.org Call us at (520)881-9662 to contact WOMB in Tucson, AZ for more information or to see if you qualify.

08/27/2020

WOMB is Enrolling for Healthy Pregnant Women who's baby is due November 2020 to March 2020 and who are 24-36 weeks to join the RSV Vaccine Study. For more details call us at (520)881-9662 www.WOMB.org

07/24/2020

WOMB is Screening for Healthy Women 24-36 weeks pregnant
to join the RSV Vaccine Study. For more details call us at (520)881-9662 https://rsvvaccinestudy.com/index.html

06/30/2020

Do You Know about RSV?

The Respiratory Syncytial Virus puts Healthy Babies born in RSV season are at risk to contract RSV. In the United States, RSV is the leading cause of infant hospitalization, with more than 60,000 hospitalizations of children 12 months of age and younger annually.

Maternal immunization to protect infants early in life offers a strategy for preventing this virus is infants. This vaccine will be given to pregnant women in the second or third trimester of pregnancy, this will produce sufficient antibody titers via trans-placental transfer of antibody to the fetus.

This antibody would then help to protect infants early in life, when they are most at risk for severe RSV disease.

Call us to see if you qualify to participate at (520)881-9662 or visit www.WOMB.org

06/25/2020

CLINICAL TRIAL-SUPPORTED
We are committed to producing our formulas the right way, with data-driven research. In partnership with pediatric practices nationwide, we are currently conducting a large-scale clinical trial in accordance with U.S. Food and Drug Administration’s rigorous requirements. We’re studying how nutrition supports a baby’s growth, but moreover its impact on a baby’s holistic health and development.

Hand-Picked Ingredients
HAND-PICKED INGREDIENTS
While breast milk is nature’s gold standard, we are here to support your baby’s feeding – however you do it. We take great pride in what goes into our blend…and what we keep out.

No corn syrup, no soy, no palm oil, no GMOs. No thank you.

Call WOMB at (520)881-9662

06/24/2020

The ByHeart Family
Since we’re so into your family, we thought you might want to meet ours.We are world-class doctors, pediatric researchers, seasoned formula experts, dedicated blendmasters, and passionate parents. Above all, we are just people who believe in feeding freedom, which means all parents have the very best choices, whenever and wherever you need them. byheart.com

06/24/2020

MEET BYHEART
A Holistic Approach to Baby Health
Breastfeeding doesn’t work for all parents, or not all the time. Thankfully, advances in breastmilk research are allowing us to raise the bar on baby’s first foods: ByHeart combines leading nutrition science with next-to-nature quality, hand-picked ingredients, small-batch blending and rigorous quality controls, so everything your baby eats sets the stage for a healthy life to follow. Our products are made to empower your instincts – because you know your baby by heart. byheart.com

Call WOMB at (520)881-9662

06/19/2020

Giving expecting mothers an investigational vaccine
for respiratory syncytial virus (RSV) is safe and could help
protect their babies from RSV after they are born.
RSV is known to cause common illnesses of the airways.
In fact, it is the most common cause of bronchiolitis
(inflammation of the small airways) and pneumonia
(infection of the lungs) in children under 12 months. www.womb.org